Wall Street Zen upgraded shares of Zepp Health (NYSE:ZEPP – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday.
Separately, Fundamental Research set a $53.01 target price on shares of Zepp Health and gave the stock a “buy” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $53.01.
Read Our Latest Analysis on ZEPP
Zepp Health Price Performance
Insider Transactions at Zepp Health
In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the completion of the transaction, the chief financial officer directly owned 114,539 shares in the company, valued at $528,024.79. The trade was a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by company insiders.
Institutional Investors Weigh In On Zepp Health
Large investors have recently modified their holdings of the business. Public Employees Retirement System of Ohio increased its stake in shares of Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock valued at $41,000 after purchasing an additional 576 shares during the last quarter. Harvest Fund Management Co. Ltd lifted its position in shares of Zepp Health by 6.7% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after buying an additional 2,800 shares during the last quarter. Osaic Holdings Inc. boosted its stake in Zepp Health by 239.5% in the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after buying an additional 5,845 shares in the last quarter. Dimensional Fund Advisors LP acquired a new stake in Zepp Health in the fourth quarter valued at about $241,000. Finally, Capstone Capital Management Ltd acquired a new stake in Zepp Health in the fourth quarter valued at about $298,000. Institutional investors and hedge funds own 52.61% of the company’s stock.
Zepp Health Company Profile
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Featured Articles
- Five stocks we like better than Zepp Health
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
